首页>
外国专利>
- IL-2 PD-L1 COMBINATION THERAPY OF TUMOR-TARGETED IL-2 VARIANT IMMUNOCYTOKINES AND ANTIBODIES AGAINST HUMAN PD-L1
- IL-2 PD-L1 COMBINATION THERAPY OF TUMOR-TARGETED IL-2 VARIANT IMMUNOCYTOKINES AND ANTIBODIES AGAINST HUMAN PD-L1
展开▼
机译:-针对人PD-L1的肿瘤靶向IL-2各种免疫细胞因子和抗体的IL-2 PD-L1联合治疗
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention relates to a combination therapy of a specific tumor-target IL-2 mutant immunoglobulin cytokine and a specific antibody that binds human PD-L1.
展开▼